mRNA vaccines: a lucky shot? Bruegel Working Paper December 2021.
MRNA technology has proved in the context of the COVID-19 pandemic its breakthrough value as a basis for vaccines. There has been rapid development of highly safe, effective and robust mRNA vaccines, and these can be delivered at large scale. Yet the technology is the result of a long process of acc...
| Corporate Author: | |
|---|---|
| Format: | Electronic Kit |
| Language: | Undetermined |
| Published: |
2021-12
|
| Subjects: |
This item is not available through EZBorrow. Please contact your institution’s interlibrary loan office for further assistance.